![]() |
|
|
Vol. 290, Issue 2, 672-677, August 1999
-Lactam Antibiotics with the
Cloned Rat Renal Organic Anion Transporter 11
Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan (S.J., T.S., M.T., N.A., Y.K., H.E.); and Department of Physiology, Faculty of Science, Mahidol University, Bangkok, Thailand (S.J., N.A., S.S.)
| |
Abstract |
|---|
|
|
|---|
In the present study, we investigated the interactions between
antibiotics, especially
-lactam antibiotics, and rat renal organic
anion transporter 1 (OAT1).
[14C]p-Aminohippurate (PAH) uptake via
OAT1 expressed in Xenopus laevis oocytes was inhibited
by all of the penicillins and cephalosporins tested. Penicillin G,
carbenicillin, cephaloridine, cephalothin, cefazolin, and cephalexin
inhibited [14C]PAH uptake via OAT1 in a competitive
manner (Ki = 0.29-2.33 mM). Cinoxacin,
a quinolone gyrase inhibitor, also inhibited PAH uptake via OAT1. Other
antibiotics, such as gentamicin, streptomycin, and vancomycin, which do
not contain anionic moieties, did not interact with OAT1.
[3H]Penicillin G and [14C]cephaloridine
were demonstrated to be transported via OAT1. Using the cells that
stably expressed OAT1, we analyzed the cytotoxicity of several
-lactam antibiotics. Cells expressing OAT1 showed higher
susceptibility to cephaloridine (a potentially nephrotoxic
-lactam
antibiotic) toxicity than did control cells. The present study suggests
that OAT1 is the major organic anion transporter in the kidney that is
responsible for the renal secretion of antibiotics, especially that of
-lactam antibiotics. Furthermore, the culture cell system expressing
OAT1 was revealed to be useful for the prediction of the nephrotoxicity
of
-lactam antibiotics.
| |
Introduction |
|---|
|
|
|---|
The
excretion of drugs and their metabolites is an important function of
the kidney. A variety of clinically important drugs are classified as
organic anions, and the proximal tubule cells possess secretory
pathways specific for organic anions. There are several anion transport
systems in proximal tubule cells, such as the sulfate/oxalate
exchanger, Na+-dicarboxylate cotransporter, and
p-aminohippurate (PAH) transporter (Ullrich and Rumrich,
1988
). Among them, the PAH transporter is known to be a
multispecific organic anion transporter and is considered to play a
central role in the excretion of xenobiotics from the kidney (Pritchard
and Miller, 1993
).
Recently, a renal organic anion transporter, organic anion transporter
1 (OAT1), was isolated from rat kidney (Sekine et al., 1997
; Sweet et
al., 1997
). OAT1 was shown to mediate the transport of PAH, cyclic AMP,
cGMP, prostaglandin E2, urate,
-ketoglutarate, and methotrexate when expressed in Xenopus laevis oocytes,
and [14C]PAH uptake via OAT1 was inhibited by
various anionic drugs. OAT1 is considered to be the multispecific
organic anion transporter responsible for the excretion of anionic
drugs from the kidney.
-Lactam antibiotics (penicillins, cephalosporins, and
carbapenems) are among the most important groups of drugs
excreted by the kidney (Nightingale et al., 1975
; Kamiya et al., 1983
; Tune et al., 1997
). Based on previous in vivo pharmacokinetic analyses,
-lactam antibiotics are suggested to be not only filtered through
the glomerulus but also actively secreted by the proximal tubules. It
has been reported that secretion of penicillin G (PCG) by proximal
tubule cells of the kidney is sensitive to probenecid (Barza et al.,
1975
; Bergeron et al., 1975
; Nierenberg, 1987
; Tsuji et al., 1990
). PCG
exerted a moderate inhibitory potency on the contraluminal PAH
transport (Ullrich et al., 1989
; Makhuli et al., 1995
). Cephalosporins
inhibited PAH uptake in rat renal slices (Hori et al., 1982
) and renal
plasma membrane vesicles (Takano et al., 1989
). Cephaloridine, a
cephalosporin that possesses both anionic and cationic moieties,
inhibited PAH transport but not N-methylnicotinamide
transport in basolateral membrane vesicles (Kasher et al., 1983
). Thus,
-lactam antibiotics have been considered as being secreted by the S2
segment of the proximal tubule via the PAH transporter system (Moller
and Sheikh, 1983
; Ullrich et al., 1989
). The relatively short serum
half-life of
-lactam antibiotics has been attributed to this active
secretion via the renal organic anion transporter.
On the other hand, several cephalosporins such as cephaloridine and
cephalothin have been shown to be toxic to the renal proximal tubule
cells (Barza, 1978
). Cephaloridine, after being taken up by the
proximal tubule cells, causes acute proximal tubular necrosis in humans
and laboratory animals (Goldstein et al., 1988
). The transport of
-lactam antibiotics via a renal organic anion transporter is
important to understand their pharmacokinetics and toxicokinetics.
Because OAT1 is presumed to be the major renal organic anion
transporter, we investigated the interaction and transport of
-lactam antibiotics via OAT1. Furthermore, we studied the
cytotoxicity of these drugs using kidney-derived culture cells
expressing OAT1.
| |
Experimental Procedures |
|---|
|
|
|---|
Materials. [14C]PAH (2.0 GBq/mmol) was purchased from DuPont-NEN (Boston, MA). [phenyl-4(n)-3H]Benzylpenicillin (666 GBq/mmol) was purchased from Amersham International, Ltd. (Buckinghamshire, UK). [14C]Cephaloridine (514 MBq/mmol) was supplied by Sankyo Co. (Tokyo, Japan). Collagenase was purchased from Boehringer Mannheim (Indianapolis, IN). Dulbecco's modified Eagle's medium was purchased from Nissui Pharmaceutical Co., Ltd. (Tokyo, Japan). All other compounds used in the present study were purchased from Sigma Chemical Co. (St. Louis, MO).
cRNA Synthesis.
Capped cRNAs for OAT1 were synthesized in
vitro using T7 RNA polymerase as described elsewhere (Sekine et al.,
1997
).
Oocyte Isolation. X. laevis oocytes were digested in OR2 solution containing 82.5 mM NaCl, 2 mM KCl, 1 mM MgCl2, 5 mM HEPES, pH 7.5, and 1.5 mg/ml collagenase for 30 to 40 min at room temperature. After digestion, the oocytes were defolliculated and kept in Barth's medium containing 88 mM NaCl, 1 mM KCl, 0.33 mM Ca(NO3)2 · 4H2O, 0.41 mM CaCl2 · 2H2O, 0.82 mM MgSO4 · 7H2O, 2.4 mM NaHCO3, and 10 mM HEPES, pH 7.4, at room temperature until cRNA injection, which was performed on the same day.
Oocyte Injection. The defolliculated oocytes were injected with OAT1-cRNA and the control oocytes with 50 nl of distilled water. After injection, the oocytes were incubated in Barth's medium supplemented with 0.05 mg/ml gentamicin at 18°C for 2 to 3 days.
Transport and Inhibition Studies. At 2 to 3 days after cRNA injection, transport studies were performed. The oocytes were preincubated in ND96 solution containing 1 mM glutarate for 2 to 3 h to generate an outwardly directed glutarate gradient before the uptake or inhibition studies. After the glutarate was washed off, the oocytes were transferred to ND96 solution containing 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2 · 2H2O, 1 mM MgCl2 · 6H2O, 5 mM HEPES, pH 7.4, and a radiolabeled substrate ([14C]PAH, [3H]PCG, or [14C]cephaloridine), and were incubated with or without nonradiolabeled drugs. For inhibition studies, norfloxacin, erythromycin, and chloramphenicol were first dissolved in dimethyl sulfoxide, and diluted to 2 mM in ND96 solution. All other inhibitors were dissolved directly in ND96 solution. The incubation was terminated by adding ice-cold ND96 solution, and the oocytes were washed five times with icecold ND96 solution. Each oocyte was transferred to a scintillation vial and solubilized in 0.25 ml of 10% SDS. After the addition of 2.5 ml of Aquasol-2, the radioactivity in each oocyte was counted with a liquid scintillation counter (LSC-3100; Aloka, Tokyo, Japan).
Kinetic Analysis.
After preincubation with glutarate, the
oocytes expressing OAT1 were incubated for 1 h in ND96 solution
with various concentrations of PAH in the presence or absence of
-lactam antibiotics. A Lineweaver-Burk plot was used to evaluate the
type of inhibition. Because all the drugs tested revealed competitive
inhibition of PAH uptake, the Ki value
for each drug was calculated from the following equation: Ki = concentration of
inhibitor/[(KmPAH with
inhibitor/KmPAH without inhibitor)
1].
Cytotoxicity Test of
-Lactam Antibiotics in S3 Cells.
We
had previously established a cell line derived from the terminal
portion of the mouse proximal tubule (S3) that was microdissected from
the kidneys of SV40 large T-antigen-harboring transgenic mice
(Hosoyamada et al., 1996
). OAT1-expressing S3 cells were obtained by
transfecting S3 cells with OAT1 cDNA in the mammalian expression vector
pcDNA3.1 by the electroporation method. S3 cells expressing OAT1 and
the mock S3 cells were used in this experiment. Both were subcultivated
in a 96-well plate at a concentration of 9 × 103 cells/well and cultured in Dulbecco's
modified Eagle's medium in the presence or absence of different
concentrations of drugs. Cell viability was determined by the staining
of basophilic cellular compounds, mainly nucleic acids, using the
methylene blue colorimetric technique 3 days after subcultivation
(Pelletier et al., 1988
; Monks et al., 1991
). This procedure provides
rapid data collection compared with cell counting or DNA extraction
methods. Briefly, the cells were washed three times with 0.15 M PBS, pH
7.4, and fixed with 100 µl of 10% (v/v) Formalin in PBS at room
temperature for 10 min. After being washed three times with 0.01 M
borate buffer, pH 8.4, the cells were stained with 1% methylene blue in 100 µl of borate buffer at room temperature for 10 min. They were
then washed and solubilized in 100 µl of 0.1 N HCl. The optical densities (O. D.) of the samples were measured at 662 nm using a
spectrophotometer (DU640; Beckman Instruments, Berkeley, CA). Data are
expressed in terms of percent cell viability [(O. D. of treated
cells/O. D. of control cells) × 100].
Statistical Analysis. In oocyte experiments, 6 to 10 oocytes were used. For cell experiments, three wells were used for each drug concentration. The values obtained in each experiment were expressed as the mean ± S.E. Statistical comparisons between the two groups were performed using the Student's unpaired t test.
| |
Results |
|---|
|
|
|---|
Inhibitory Effects of
-Lactam Antibiotics on OAT1-Mediated
[14C]PAH Uptake.
The inhibitory effects of
antibiotics on [14C]PAH uptake were determined
in oocytes expressing OAT1. Figure 1A
shows the result for penicillins. All of the tested penicillins
inhibited [14C]PAH uptake. At 2 mM,
cloxacillin, nafcillin, and piperacillin almost totally abolished the
uptake of 2 µM [14C]PAH, whereas PCG showed
only a moderate inhibitory effect. Figure 1B shows the results for
cephalosporins. All of the cephalosporins tested at a concentration of
2 mM inhibited [14C]PAH uptake. Cefamandole and
cephalothin exhibited the most potent inhibitory activity. Cefotaxime
and cefadroxil showed a low affinity for OAT1. The three zwitterions
(cephaloridine, cefsulodin, and ceftazidime), as well as other anionic
cephalosporins, inhibited PAH uptake by oocytes expressing OAT1.
Cefsulodin, with an additional sulfonic group, was the most effective
among the three zwitterions.
|
Kinetic Analysis of Drug Inhibition of [14C]PAH
Uptake.
Among the 17
-lactam antibiotics tested in the above
experiments, the inhibitory kinetics of two penicillins and four
cephalosporins were analyzed with respect to OAT1-mediated
[14C]PAH uptake. The double-reciprocal plot of
PCG and cephaloridine is shown in Fig. 2.
The results revealed that the maximum velocity of PAH transport via
OAT1 was not altered by PCG and cephaloridine. The result with four
other drugs (i.e., carbenicillin, cephalothin, cefazolin, and
cephalexin) also indicated a competitive type of inhibition (data not
shown). The Ki values of all the six
drugs are shown in Table 1.
|
|
Uptake of Radiolabeled PCG and Cephaloridine.
The transport of
PCG and cephaloridine were directly determined in oocytes expressing
OAT1. The results of [3H]PCG and
[14C]cephaloridine uptake by control oocytes
and OAT1-expressing oocytes are presented in Fig.
3. The uptake rate of 100 µM
[3H]PCG and
[14C]cephaloridine by OAT1-expressing oocytes
(7.02 ± 0.68 and 8.77 ± 0.64 pmol/oocyte/3 h) were
significantly higher than that by control oocytes (2.62 ± 0.23 and 2.56 ± 0.17 pmol/oocyte/3 h).
|
Cytotoxicity Test.
Figure 4
shows relative cell viability after treatment with several
-lactam
antibiotics of mouse S3 proximal tubule cells expressing OAT1 and mock
S3 cells. When exposed to cephaloridine at concentrations of 0.2, 0.5, 0.7, and 1 mM, viability of S3 cells expressing OAT1 decreased to a
greater extent than that of mock S3 cells. At much higher
concentrations, cephaloridine showed cytotoxicity against both types of
cells. When exposed to cephalothin, viability of S3 cells expressing
OAT1 was reduced significantly only at a concentration of 0.5 mM. Other
drugs, such as amoxicillin and ampicillin, did not show any differences in cytotoxic activity for OAT1- expressing and mock S3 cells.
|
| |
Discussion |
|---|
|
|
|---|
OAT1 is a multispecific organic anion transporter exclusively
located on the basolateral membrane of the middle proximal tubule, S2
segment (Tojo et al., 1999
). PAH is a high-affinity substrate of OAT1
(Km = 14.3 µM), and OAT1-mediated
PAH transport was inhibited by a variety of anionic drugs (Sekine et
al., 1997
). OAT1 is an organic anion/dicarboxylate exchanger;
preloaded glutarate trans-stimulates the uptake of PAH via
OAT1 (Sekine et al., 1997
). From these findings, we inferred that OAT1
is the major renal organic anion transporter at the basolateral
membrane of the proximal tubule. However, the contribution of OAT1 in
the renal excretion of organic anions remains to be elucidated. In
fact, we have already identified several isoforms of OAT1 (Sekine et
al., 1998
), one of which shows higher affinity to PCG.
This study demonstrated the inhibition of PAH transport via OAT1 by all
the penicillins and cephalosporins tested and OAT1-mediated transport
of [3H]PCG and
[14C]cephaloridine (Fig. 3). The present data
are in good agreement with those obtained in membrane vesicles (Kasher
et al., 1983
; Takano et al., 1989
; Tsuji et al., 1990
) and renal
cortical slices (Hori et al., 1982
; Nierenberg, 1987
). In these
reports, the inhibitory effect of various
-lactam antibiotics on the
renal organic anion transporter were reported relatively weak. The
Ki values of PCG, cephalexin, and
cephaloridine for OAT1 (1.68, 2.31, and 2.33 mM, respectively) are
similar to the results of the stop-flow peritubular capillary perfusion
method (Ullrich et al., 1989
), where the
Ki values of PCG, cephalexin, and
cephaloridine are 0.81, 2.3, and >5 mM, respectively. The
IC50 value of PCG on PAH uptake by the rabbit
basolateral membrane vesicles was reported to be 500 µM (Makhuli et
al., 1995
). Furthermore, from the kinetic experiment using the in vivo
tissue-sampling single-injection technique, the
Km value of PCG transport was
determined to be 1.39 mM (Tsuji et al., 1990
). This value is identical
with the Ki for OAT1 (1.68 mM, Table
1). The comparison of inhibitory kinetics of OAT1 with those obtained
in the previous study on the renal organic anion transport pathway
strongly suggests that OAT1 plays the central role for the renal
secretion of
-lactam antibiotics.
The affinity of
-lactam antibiotics for OAT1 is not so high.
Although
-lactam antibiotics possess a core chemical structure (
-lactam ring) and an anionic moiety, they have considerably different side chains. Furthermore, the hydrophobicity of the substrate
is supposed to be closely related to its affinity for the PAH
transporter (Moller and Sheikh, 1983
; Ullrich et al., 1997
). Thus, it
is of no wonder that such hydrophilic compounds like
-lactam possess
relatively high Ki values for OAT1.
-Lactam antibiotics are only one of the substrates of the
multispecific organic anion transporter OAT1.
The patterns of interactions between quinolone gyrase inhibitors and
OAT1 are also similar to those reported previously. In humans, urinary
excretion of cinoxacin was reduced in the presence of probenecid
(Rodriguez et al., 1979
). Ullrich et al. (1993)
demonstrated weak
interactions of norfloxacin and ofloxacin with the PAH transporter, in
which the transport of the latter was not demonstrated. These authors
concluded that quinolone gyrase inhibitors not possessing a
piperazine group interact moderately with the PAH transporter,
whereas compounds with an additional piperazine group interact
weakly. Cinoxacin, a weak organic acid (pKa = 4.7) not possessing a
piperazine group, interacted with OAT1 as expected, whereas neither
norfloxacin nor ofloxacin, both of which possess a piperazine group,
interacted significantly with OAT1 (Fig. 1C).
In contrast to these anionic antibiotics, the polycationic
aminoglycoside gentamicin and vancomycin did not interact with OAT1.
Gentamicin was reported to interact with the renal organic cation/H+ exchanger but showed no inhibitory
effect on PAH transport across the renal brush-border membrane vesicles
(Sokol et al., 1989
). Vancomycin inhibited tetraethylammonium uptake
across the basolateral membrane (i.e., via the organic cation transport
pathway; Sokol, 1991
), whereas this drug did not affect PAH transport
across the basolateral membrane of the proximal tubule. Although it has
a wide substrate selectivity, substrate recognition by OAT1 is limited to antibiotics with anionic moieties.
The luminal secretion of
-lactams has also been supposed to be
performed by the carrier-mediated pathways. The transporter molecule
responsible for this luminal secretion, however, has not yet been
identified. Recently, a distinct type of multispecific organic anion
transporter, multidrug resistance-associated protein 2 (MRR2; or
canalicular multispecific organic anion transporter) MRP2 (or
cMOAT), was localized to the luminal membrane of all proximal tubule
segments (S1-S3; Shaub et al., 1997
). MRP2, a member of the ATP
binding cassette transporter superfamily, mediates the efflux of
anionic lipophilic substances, such as leukotriene C4,
leukotriene D4, glucuronides, and glutathione conjugates, from the cells (van Aubel et al., 1998
). MRP2 seems to transport more
lipophilic compounds than those by OAT1. Although there is no direct
evidence that the members of the ATP binding cassette transporter
superfamily mediate the efflux of antibiotics, they are possible
candidates for the luminal transport of
-lactams and quinolone
gyrase inhibitors. Now several isoforms of MRP2, such as MOAT-B (Lee et
al., 1998
) and MLP-1 and MLP-2 (Hirohashi et al., 1998
), have been
identified. It is of interest to investigate the possible role of these
MRP isoforms in the organic anion transport in the kidney because the
luminal secretion of organic anions, along with the basolateral uptake
of organic anions, plays the crucial role in the renal handling of
organic anions, especially
-lactams.
In general,
-lactam antibiotics are safe for clinical use; however,
several compounds are known to be potentially nephrotoxic. Cephaloridine is one of such drugs. There are two factors in the development of renal tubular damage caused by
-lactams: (1)
accumulation of
-lactams in the cell via active transport
mechanisms, followed by (2) intracellular events causing cytotoxicity
(e.g., lipid peroxidation or mitochondrial dysfunction; Tune, 1997
).
Because the nephrotoxicity of cephaloridine can be suppressed by the
concomitant administration of probenecid (Tune et al., 1977
), its toxic
effects have been partly attributed to its active uptake by proximal
tubule cells via the renal organic anion transporter. In the present study, we did not directly demonstrate the transport of
-lactams except PCG and cephaloridine. Therefore, we could not draw solid conclusion as to their transport via OAT1. Nevertheless, this system
seems to mimic well the nephrotoxicity associated with
-lactam
antibiotics. In the experiment shown in Fig. 4, we demonstrated that
culture cells expressing OAT1 revealed higher susceptibility to
cephaloridine toxicity than mock cells. In contrast, ampicillin and
amoxicillin, which are known to be non-nephrotoxic, did not show any
such toxic effects. Thus, culture cells expressing OAT1 may be used as
a screening system for nephrotoxicity of drugs. If we could use a
system of cells expressing human OAT1, it would provide more important
information regarding drug transport and possible toxicity in the human kidney.
In conclusion, this study provides for the first time the molecular
basis on the renal excretion of
-lactams and quinolone gyrase
inhibitors by renal organic anion transporter. Further studies to
identify OAT isoforms and to determine their tissue localization and
substrate selectivity will help to clarify the molecular mechanisms
underlying the pharmacokinetics of
-lactams. Cells expressing OAT1
showed higher susceptibility to the potent nephrotoxic drug
cephaloridine than mock cells. We conclude that OAT1 is responsible for
the secretion of
-lactam antibiotics and that a culture cell system
expressing OAT1 will be a useful tool for the prediction of
drug-induced nephrotoxicity.
| |
Footnotes |
|---|
Accepted for publication April 13, 1999.
Received for publication February 8, 1999.
1 This work was supported in part by grants from the Japanese Ministry of Education Science, Sports and Culture; Science Research Promotion Fund of the Japan Private School Promotion Foundation; Uehara Memorial Foundation; and Tokyo Biochemical Research Foundation.
Send reprint requests to: Dr. Hitoshi Endou, Department of Pharmacology and Toxicology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan.
| |
Abbreviations |
|---|
PAH, p-aminohippurate; OAT1, organic anion transporter 1; PCG, penicillin G; MRP2, multidrug resistance-associated protein 2; O.D., optical density.
| |
References |
|---|
|
|
|---|
-lactam antibiotics through organic anion transport systems in rat kidney and liver.
J Pharmacol Exp Ther
253:
315-320
-lactam antibiotics.
Kidney Int
36:
78-88[Medline].This article has been cited by other articles:
![]() |
N. Mizuno, T. Takahashi, H. Kusuhara, J. D. Schuetz, T. Niwa, and Y. Sugiyama Evaluation of the Role of Breast Cancer Resistance Protein (BCRP/ABCG2) and Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in The Urinary Excretion of Sulfate and Glucuronide Metabolites of Edaravone (MCI-186; 3-Methyl-1-phenyl-2-pyrazolin-5-one) Drug Metab. Dispos., November 1, 2007; 35(11): 2045 - 2052. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. VanWert, R. M. Bailey, and D. H. Sweet Organic anion transporter 3 (Oat3/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1332 - F1341. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mizuno, T. Takahashi, Y. Iwase, H. Kusuhara, T. Niwa, and Y. Sugiyama Human Organic Anion Transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) Transport Edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and Its Sulfate Conjugate Drug Metab. Dispos., August 1, 2007; 35(8): 1429 - 1434. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ci, H. Kusuhara, M. Adachi, J. D. Schuetz, K. Takeuchi, and Y. Sugiyama Involvement of MRP4 (ABCC4) in the Luminal Efflux of Ceftizoxime and Cefazolin in the Kidney Mol. Pharmacol., June 1, 2007; 71(6): 1591 - 1597. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nozaki, H. Kusuhara, T. Kondo, M. Hasegawa, Y. Shiroyanagi, H. Nakazawa, T. Okano, and Y. Sugiyama Characterization of the Uptake of Organic Anion Transporter (OAT) 1 and OAT3 Substrates by Human Kidney Slices J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 362 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Schnabolk, G. L. Youngblood, and D. H. Sweet Transport of estrone sulfate by the novel organic anion transporter Oat6 (Slc22a20) Am J Physiol Renal Physiol, August 1, 2006; 291(2): F314 - F321. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Li, G. D. Anderson, B. R. Phillips, W. Kong, D. D. Shen, and J. Wang INTERACTIONS OF AMOXICILLIN AND CEFACLOR WITH HUMAN RENAL ORGANIC ANION AND PEPTIDE TRANSPORTERS Drug Metab. Dispos., April 1, 2006; 34(4): 547 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Eraly, V. Vallon, D. A. Vaughn, J. A. Gangoiti, K. Richter, M. Nagle, J. C. Monte, T. Rieg, D. M. Truong, J. M. Long, et al. Decreased Renal Organic Anion Secretion and Plasma Accumulation of Endogenous Organic Anions in OAT1 Knock-out Mice J. Biol. Chem., February 24, 2006; 281(8): 5072 - 5083. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M Beringer and R. L Slaughter Transporters and Their Impact on Drug Disposition Ann. Pharmacother., June 1, 2005; 39(6): 1097 - 1108. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Wright and W. H. Dantzler Molecular and Cellular Physiology of Renal Organic Cation and Anion Transport Physiol Rev, July 1, 2004; 84(3): 987 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mizuno, T. Niwa, Y. Yotsumoto, and Y. Sugiyama Impact of Drug Transporter Studies on Drug Discovery and Development Pharmacol. Rev., September 1, 2003; 55(3): 425 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hasegawa, H. Kusuhara, H. Endou, and Y. Sugiyama Contribution of Organic Anion Transporters to the Renal Uptake of Anionic Compounds and Nucleoside Derivatives in Rat J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1087 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Van Bambeke, J.-M. Michot, and P. M. Tulkens Antibiotic efflux pumps in eukaryotic cells: occurrence and impact on antibiotic cellular pharmacokinetics, pharmacodynamics and toxicodynamics J. Antimicrob. Chemother., May 1, 2003; 51(5): 1067 - 1077. [Full Text] [PDF] |
||||
![]() |
A. G. Aslamkhan, Y.-H. Han, X.-P. Yang, R. K. Zalups, and J. B. Pritchard Human Renal Organic Anion Transporter 1-Dependent Uptake and Toxicity of Mercuric-Thiol Conjugates in Madin-Darby Canine Kidney Cells Mol. Pharmacol., March 1, 2003; 63(3): 590 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. L. Zhao, X. B. Cen, M. Ito, K. Yokoyama, K. Takagi, K. Kitaichi, M. Nadai, M. Ohta, K. Takagi, and T. Hasegawa Shiga-Like Toxin II Derived from Escherichia coli O157:H7 Modifies Renal Handling of Levofloxacin in Rats Antimicrob. Agents Chemother., May 1, 2002; 46(5): 1522 - 1528. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nagata, H. Kusuhara, H. Endou, and Y. Sugiyama Expression and Functional Characterization of Rat Organic Anion Transporter 3 (rOat3) in the Choroid Plexus Mol. Pharmacol., May 1, 2002; 61(5): 982 - 988. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hasegawa, H. Kusuhara, D. Sugiyama, K. Ito, S. Ueda, H. Endou, and Y. Sugiyama Functional Involvement of Rat Organic Anion Transporter 3 (rOat3; Slc22a8) in the Renal Uptake of Organic Anions J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 746 - 753. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hill, T. Cihlar, C. Oo, E. S. Ho, K. Prior, H. Wiltshire, J. Barrett, B. Liu, and P. Ward The Anti-Influenza Drug Oseltamivir Exhibits Low Potential to Induce Pharmacokinetic Drug Interactions via Renal Secretion---Correlation of in Vivo and in Vitro Studies Drug Metab. Dispos., January 1, 2002; 30(1): 13 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Islinger, M. Gekle, and S. H. Wright Interaction of 2,3-Dimercapto-1-propane Sulfonate with the Human Organic Anion Transporter hOAT1 J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 741 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Morita, H. Kusuhara, T. Sekine, H. Endou, and Y. Sugiyama Functional Characterization of Rat Organic Anion Transporter 2 in LLC-PK1 Cells J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 1179 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ohashi, I. Tamai, J.-i. Nezu, H. Nikaido, N. Hashimoto, A. Oku, Y. Sai, M. Shimane, and A. Tsuji Molecular and Physiological Evidence for Multifunctionality of Carnitine/Organic Cation Transporter OCTN2 Mol. Pharmacol., February 1, 2001; 59(2): 358 - 366. [Abstract] [Full Text] |
||||
![]() |
A. S. Mulato, E. S. Ho, and T. Cihlar Nonsteroidal Anti-Inflammatory Drugs Efficiently Reduce the Transport and Cytotoxicity of Adefovir Mediated by the Human Renal Organic Anion Transporter 1 J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 10 - 15. [Abstract] [Full Text] |
||||
![]() |
S. Wada, M. Tsuda, T. Sekine, S. H. Cha, M. Kimura, Y. Kanai, and H. Endou Rat Multispecific Organic Anion Transporter 1 (rOAT1) Transports Zidovudine, Acyclovir, and Other Antiviral Nucleoside Analogs J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 844 - 849. [Abstract] [Full Text] |
||||
![]() |
H. Uchino, I. Tamai, H. Yabuuchi, K. China, K.-i. Miyamoto, E. Takeda, and A. Tsuji Faropenem Transport across the Renal Epithelial Luminal Membrane via Inorganic Phosphate Transporter Npt1 Antimicrob. Agents Chemother., March 1, 2000; 44(3): 574 - 577. [Abstract] [Full Text] |
||||